Johnson & Johnson
Mind-altering, ketamine-like drug OK’d for severe depression
A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness. The nasal spray from Johnson & Johnson is a chemical cousin of ketamine, which has been ...
Johnson & Johnson’s stock falls after report on asbestos in baby powder
Reuters report alleges the company concealed knowledge of asbestos for decades
End of content
No more pages to load